In animal models, transduction of unfractionated murine bone marrow (BM) cells with Myc results in AML development [10], and expression of inducible anti-Myc short hairpin RNA (shRNA) in leukemic cells leads to their depletion both in vitro and in vivo [11]. Here, MYC is linked to acute myeloid leukemia.